phase-Ib/II trial of AGuIX on glioblastoma
Latest Information Update: 18 Mar 2021
Price :
$35 *
At a glance
- Drugs Gadolinium chelated polysiloxane based nanoparticle (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms NANOGBM
- Sponsors NH TherAguix
- 18 Mar 2021 New trial record